Neurent Medical, the pioneer behind Neuromark, a minimally invasive solution to treat chronic rhinitis, has closed its oversubscribed Series C financing, raising €62.5m (US$74m) to drive commercial expansion, broaden clinical evidence, and advance its product and indication pipeline.
The financing was led by MVM Partners, with significant participation from Sofinnova...
dsm-firmenich, a global nutrition, health, and beauty company, has entered into an agreement with CVC to divest its Animal Nutrition & Health (ANH) business for an enterprise value of about €2.2bn (US$2.6bn), which includes an earnout of up to €500m implying a 7x EV/Adjusted EBITDA multiple, based on ANH’s normalised Adjusted Ebitda. dsm-firmenich will retain a 20% equity stake in the divested ANH Companies, in partnership with CVC.
ANH is a global provider of science-based animal nutrition and health solutions. The business offers products ranging from vitamins over premixes, to...
